STOCK TITAN

Major Aveanna (AVAH) holder trims stake, keeps 10.1M shares

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Aveanna Healthcare Holdings’ major shareholder group reported an open-market sale of common stock. An entity associated with J.H. Whitney Equity Partners VII, LLC sold 2,419,035 shares of Aveanna common stock at $8.01 per share on June 30, 2026.

After this transaction, that entity held 10,112,123 shares indirectly, while related entities held 1,426,034 and 15,523,810 shares indirectly. The reporting person and its affiliates may be deemed to share voting and dispositive power over these holdings but disclaim beneficial ownership beyond their pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider J.H. Whitney Equity Partners VII, LLC
Role 10% Owner
Sold 2,419,035 shs ($19.38M)
Type Security Shares Price Value
Sale Common Stock, $0.01 par value 2,419,035 $8.01 $19.38M
holding Common Stock, $0.01 par value -- -- --
holding Common Stock, $0.01 par value -- -- --
holding Common Stock, $0.01 par value -- -- --
Holdings After Transaction: Common Stock, $0.01 par value — 10,112,123 shares (Indirect, By J.H. Whitney VII, L.P.); Common Stock, $0.01 par value — 0 shares (Direct); Common Stock, $0.01 par value — 15,523,810 shares (Indirect, By PSA Healthcare Investment Holdings LLC); Common Stock, $0.01 par value — 1,426,034 shares (Indirect, By PSA Iliad Holdings LLC)
Footnotes (1)
  1. F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Shares sold 2,419,035 shares Open-market sale of common stock
Sale price $8.01/share Price for the 2,419,035-share sale
Post-sale holdings (J.H. Whitney VII, L.P.) 10,112,123 shares Indirect Aveanna common stock after sale
Holdings via PSA Iliad Holdings LLC 1,426,034 shares Indirect Aveanna common stock
Holdings via PSA Healthcare Investment Holdings LLC 15,523,810 shares Indirect Aveanna common stock
Net shares sold 2,419,035 shares Net sell activity in this Form 4
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
voting and dispositive power financial
"may be deemed to share voting and dispositive power with respect to shares"
beneficial ownership financial
"disclaims beneficial ownership of such securities except to the extent"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of its pecuniary interest"
ten percent owner financial
"is_ten_percent_owner": 1"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did the Aveanna Healthcare (AVAH) insider group do in this Form 4?

An entity associated with J.H. Whitney Equity Partners VII, LLC reported an open-market sale of 2,419,035 Aveanna shares at $8.01 each, while also updating its indirect ownership stakes held through several affiliated investment entities.

How many Aveanna (AVAH) shares were sold and at what price?

The filing reports an open-market sale of 2,419,035 shares of Aveanna common stock at a price of $8.01 per share, executed on June 30, 2026, by an investment entity associated with J.H. Whitney Equity Partners VII, LLC.

How many Aveanna (AVAH) shares does the selling entity hold after the sale?

Following the 2,419,035-share sale, the J.H. Whitney VII, L.P. entity held 10,112,123 Aveanna common shares indirectly, according to the Form 4. This reflects its remaining stake through that partnership after completing the reported open-market transaction.

Does J.H. Whitney Equity Partners VII, LLC claim full beneficial ownership of Aveanna (AVAH) shares?

No. The footnote states J.H. Whitney Equity Partners VII, LLC and Whitney Strategic Partners VII, L.P. may be deemed to share voting and dispositive power but each disclaims beneficial ownership of the Aveanna shares except to the extent of its pecuniary interest.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
J.H. Whitney Equity Partners VII, LLC

(Last)(First)(Middle)
212 ELM STREET

(Street)
NEW CANAAN CONNECTICUT 06840

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value0D(1)
Common Stock, $0.01 par value06/30/2026S2,419,035D$8.0110,112,123IBy J.H. Whitney VII, L.P.(1)
Common Stock, $0.01 par value15,523,810IBy PSA Healthcare Investment Holdings LLC(1)
Common Stock, $0.01 par value1,426,034IBy PSA Iliad Holdings LLC(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
/s/ David Zatlukal, Attorney-in-Fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)